Human Genome Epidemiology Literature Finder
Records 1 - 23 (of 23 Records) |
Query Trace: Breast Neoplasms and UGT2B7[original query] |
---|
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast cancer research : BCR 2004 6 (5): R488-98. Sparks Rachel, Ulrich Cornelia M, Bigler Jeannette, Tworoger Shelley S, Yasui Yutaka, Rajan Kumar B, Porter Peggy, Stanczyk Frank Z, Ballard-Barbash Rachel, Yuan Xiaopu, Lin Ming Gang, McVarish Lynda, Aiello Erin J, McTiernan An |
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast cancer research and treatment 2010 Jan 119 (2): 463-74. Authors are not available |
Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites. Cancer research 2009 Mar 69 (5): 1892-900. Blevins-Primeau Andrea S, Sun Dongxiao, Chen Gang, Sharma Arun K, Gallagher Carla J, Amin Shantu, Lazarus Phil |
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Sep 20 (9): 1937-43. Ahern Thomas P, Christensen Mariann, Cronin-Fenton Deirdre P, Lunetta Kathryn L, Søiland Håvard, Gjerde Jennifer, Garne Jens Peter, Rosenberg Carol L, Silliman Rebecca A, Sørensen Henrik Toft, Lash Timothy L, Hamilton-Dutoit Steph |
Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer. Breast cancer research : BCR 2011 13 (3): R57. Parmar Sumit, Stingl Julia Carolin, Huber-Wechselberger Ariana, Kainz Alexander, Renner Wilfried, Langsenlehner Uwe, Krippl Peter, Brockmöller Jürgen, Haschke-Becher Elisabe |
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma. Clinical pharmacology and therapeutics 2011 May 89 (5): 708-17. Mürdter T E, Schroth W, Bacchus-Gerybadze L, Winter S, Heinkele G, Simon W, Fasching P A, Fehm T, , Eichelbaum M, Schwab M, Brauch |
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. Journal of the National Cancer Institute 2012 Mar 104 (6): 452-60. Rae James M, Drury Suzy, Hayes Daniel F, Stearns Vered, Thibert Jacklyn N, Haynes Ben P, Salter Janine, Sestak Ivana, Cuzick Jack, Dowsett Mitch, |
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Feb . Vulsteke C, Lambrechts D, Dieudonné A, Hatse S, Brouwers B, van Brussel T, Neven P, Belmans A, Schöffski P, Paridaens R, Wildiers H |
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment 2014 Oct 147 (3): 557-70. Vulsteke C, Pfeil A M, Schwenkglenks M, Pettengell R, Szucs T D, Lambrechts D, Peeters M, van Dam P, Dieudonné A S, Hatse S, Neven P, Paridaens R, Wildiers |
Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. PloS one 2015 10 (7): e0132269. Romero-Lorca Alicia, Novillo Apolonia, Gaibar María, Bandrés Fernando, Fernández-Santander A |
A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. Clinical breast cancer 2015 Sep . Sawyer Michael B, Pituskin Edith, Damaraju Sambasivarao, Bies Robert R, Vos Larissa J, Prado Carla M M, Kuzma Michelle, Scarfe Andrew G, Clemons Mark, Tonkin Katia, Au Heather-Jane, Koski Sheryl, Joy Anil A, Smylie Michael, King Karen, Carandang Diana, Damaraju Vijaya L, Hanson John, Cass Carol E, Mackey John |
Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. Clinical pharmacokinetics 2016 Apr . Sutiman Natalia, Lim Joanne Siok Liu, Muerdter Thomas E, Singh Onkar, Cheung Yin Bun, Ng Raymond Chee Hui, Yap Yoon Sim, Wong Nan Soon, Ang Peter Cher Siang, Dent Rebecca, Schroth Werner, Schwab Matthias, Khor Chiea Chuen, Chowbay Balr |
Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms. Xenobiotica; the fate of foreign compounds in biological systems 2016 Mar 1-10. Street Christina M, Zhu Zhaohui, Finel Moshe, Court Michael |
Association between UDP-glucuronosyltransferase 2B7 tagSNPs and breast cancer risk in Chinese females. Clinical and experimental pharmacology & physiology 2018 05 45 (5): 437-443. He Bao-Xia, Qiao Bin, Lam Alfred King-Yin, Zhao Xiu-Li, Zhang Wen-Zhou, Liu H |
Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy. Yonsei medical journal 2019 Jan 60 (1): 30-37. Li Hai, Hu Bo, Guo Zhe, Jiang Xueqing, Su Xinyu, Zhang Xiao |
RS7435335 located in the UGT2B7 gene may be a possible genetic marker for the clinical response and prognosis of breast cancer patients receiving neoadjuvant chemotherapy. Journal of cellular biochemistry 2018 Dec . Mou Peng, Wang HuiJun, An Liping, Yin Qiang, Chang Ju |
Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis. Gene 2019 May 706 115-123. Shen Ming-Li, Xiao An, Yin Sun-Jun, Wang Ping, Lin Xiao-Qian, Yu Chen-Bin, He Gong-H |
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study. Clinical pharmacology and therapeutics 2019 Feb . Arbitrio Mariamena, Scionti Francesca, Altomare Emanuela, Di Martino Maria Teresa, Agapito Giuseppe, Galeano Teresa, Staropoli Nicoletta, Iuliano Eleonora, Grillone Francesco, Fabiani Fernanda, Caracciolo Daniele, Cannataro Mario, Arpino Grazia, Santini Daniele, Tassone Pierfrancesco, Tagliaferri Pierosand |
Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC cancer 2019 Dec 19 (1): 1257. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer. Clinical breast cancer 2021 Mar . Joy Anil A, Vos Larissa J, Pituskin Edith, Cook Sarah F, Bies Robert R, Vlahadamis Ann, King Karen, Basi Sanraj K, Meza-Junco Judith, Mackey John R, Stanislaus Avalyn, Damaraju Vijaya L, Damaraju Sambasivarao, Sawyer Michael |
Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. Frontiers in pharmacology 2021 12 12 661443. Miranda Carla, Galleguillos Macarena, Torres Roberto, Tardón Karla, Cáceres Dante D, Lee Kuen, Redal María A, Varela Nelson M, Quiñones Luis |
Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL. Pharmacogenomics and personalized medicine 2022 3 15 215-225. Li Jian, Luo Hui, Liu Ying-Ying, Chen Li-Xin, Zhu Mei-Qin, Deng Quan-Tong, Zhu Dong-Mei, Wang Zi-Mo, Xu Jin-Fe |
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & clinical pharmacology 2023 10 . Ivana Šušak Sporiš, Nada Božina, Iva Klarica Domjanovi?, Davor Sporiš, Silvio Baši?, Ivana Baši?, Mila Lovri?, Lana Ganoci, Vladimir Trkul |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: